Adze-1.17-CD40L

N/A

Report date: 2023/03/06 10:50:07

Base Information

Drug NameAdze-1.17-CD40L
Drug Alias NameAdze-1.17-CD40L
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCD40 ligand stimulants
TargetsCD40 ligand
Therapy Area/IndicationsGanglioglioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdze Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdze Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsGanglioglioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A